|
시장보고서
상품코드
1812438
세계의 비타민 D 요법 시장 : 유형별, 투여경로별, 투여형별, 용도별, 연령층별, 성별, 유통채널별, 최종사용자별, 지역별Vitamin D Therapy Market, By Type, By Route of Administration, By Dosage Form, By Application, By Age Group, By Gender, By Distribution Channel, By End User H, By Geography |
||||||
세계의 비타민 D 요법 시장은 2025년 26억 4,000만 달러로 추정되고, 2023년까지 56억 2,000만 달러에 이를 전망으로, 2025년부터 2032년까지 연평균 성장률(CAGR) 11.3%로 성장이 예측되고 있습니다.
| 보고 범위 | 보고서 세부정보 | ||
|---|---|---|---|
| 기준연도 | 2024년 | 2025년 시장 규모 | 26억 4,000만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2020-2024년 |
| 예측기간 : 2025-2032년 CAGR : | 11.30% | 2032년 가치 예측 | 56억 2,000만 달러 |
세계 비타민 D 요법 시장은 비타민 D 결핍증이 널리 만연하고 많은 건강 상태와 상관이 있다는 인식이 높아지면서 의약품 및 영양보조식품 업계 중에서도 급속히 확대되고 있는 분야입니다. 비타민 D 요법은 결핍 상태를 해결하고 최적의 뼈 건강, 면역 기능, 종합 건강을 지원하도록 설계된 경구 보충제, 주사제, 강화 제품 등 다양한 제제를 포함합니다.
골다공증, 구루병, 기타 골관련 질환, 특히 고령화 사회와 일광욕 기회가 제한된 사람들 사이에서 증가하는 경향이 있기 때문에 시장은 크게 성장하고 있습니다. 의료 관계자들 사이에서는 비타민 D가 골격 건강뿐만 아니라 심혈관계 건강, 면역계 지원, 만성 질환 예방에도 도움이 될 수 있음을 인식하게 되었습니다. 치료에 대한 응용은 내분비학과 정형외과에서 일반 의료 및 예방 의료에 이르기까지 여러 의료 전문 분야에 걸쳐 있습니다. 시장 확대는 소비자 의식 증가, 결핍증 검출을 위한 진단 능력의 향상, 새로운 치료제의 규제 승인에 의해 더욱 지원되고 있습니다.
시장 역학
세계의 비타민 D 요법 시장은 비타민 D 결핍증의 우려할 만연을 포함한 몇 가지 주요 촉진요인에 밀려 있습니다. 노인은 피부 합성 능력의 저하나 식사로부터의 섭취 제한에 의해 결핍증의 리스크가 높아져, 골다공증이나 골절, 관련 합병증을 예방하기 위해서 비타민 D를 보충할 필요가 있기 때문입니다. 뼈의 건강뿐만 아니라 면역계 지원, 심혈관 보호, 잠재적인 항염증 작용 등 비타민 D의 다면적 건강 효과에 대한 의료 전문가와 소비자의 의식 증가는 치료 용도와 시장 범위를 확대하고 있습니다.
그러나 비타민 D의 과다 복용은 독성과 고칼슘 혈증을 유발할 수 있으며, 의료 제공업체와 환자 사이에 주저함을 일으키기 때문에 용법 및 용량의 권장을 둘러싼 규제의 복잡성이나 안전성에 대한 우려 등 시장 성장은 현저한 억제요인에 직면하고 있습니다. 비타민 D 검사 및 치료 프로토콜에 대한 세계 표준화 지침이 없기 때문에 시장이 단편화되고 다른 지역에서 일관된 도입이 제한됩니다. 게다가, 저가의 제네릭 보충제 및 시판되는 대체품이 이용가능하다는 것은 프리미엄 치료 분야의 성장에 영향을 미칠 수 있습니다. 이러한 과제에도 불구하고 자가면역질환, 암 예방, 정신건강 등 새로운 치료분야에의 응용이 확대되고, 비타민 D의 보다 광범위한 생리적 역할을 실증하는 임상연구가 진행되고 있기 때문에 큰 비즈니스 기회가 탄생하고 있습니다. 또한, 신흥 시장에서의 의료 인프라 정비의 진전은 충분한 의료 서비스를 받지 않은 사람들의 미충족 의료 수요에 대응을 목표로 하는 제조업체에 있어서, 큰 사업 확대의 가능성을 나타내고 있습니다.
본 조사의 주요 특징
- 본 보고서에서는 세계의 비타민 D 요법 시장을 상세하게 분석하여 2024년을 기준연도로 한 예측기간(2025-2032년) 시장 규모(10억 달러)와 연간 평균 성장률(CAGR%)을 제공합니다.
- 또한 다양한 부문에 걸친 잠재적인 수익 기회를 밝히고 이 시장의 매력적인 투자 제안 행렬에 대해 설명합니다.
- 또한 시장 성장 촉진요인, 억제요인, 기회, 신제품의 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채용하는 경쟁 전략 등에 관한 중요한 고찰도 제공합니다.
- 기업 하이라이트, 제품 포트폴리오, 주요 하이라이트, 성과, 전략 등의 매개변수를 바탕으로 세계 비타민 D 요법 시장의 주요 기업 프로파일을 제공합니다.
- 이 보고서의 통찰을 통해 마케팅 담당자와 기업 경영진은 향후 제품 출시, 타이핑, 시장 확대, 마케팅 전술에 대한 정보를 바탕으로 의사 결정을 내릴 수 있습니다.
- 세계 비타민 D 요법 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 참가자, 재무 분석가 등 이 업계의 다양한 이해관계자를 대상으로 합니다.
- 세계의 비타민 D 요법 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 이해관계자들은 의사결정이 용이해집니다.
목차
제1장 조사의 목적과 전제조건
- 조사 목적
- 전제조건
- 약어
제2장 시장 전망
- 보고서 설명
- 시장 정의와 범위
- 주요 요약
제3장 시장 역학, 규제, 동향 분석
- 시장 역학
- 성장 촉진요인
- 억제요인
- 기회
- 영향 분석
- 주요 발전
- 규제 시나리오
- 제품 출시/승인
- PEST 분석
- Porter's Five Forces 분석
- 합병과 인수 시나리오
- 업계 동향
제4장 세계의 비타민 D 요법 시장, 유형별, 2020-2032년
- 일반의약품(OTC)
- 처방약
제5장 세계의 비타민 D 요법 시장, 투여 경로별, 2020-2032년
- 경구
- 비경구(주사액)
제6장 세계의 비타민 D 요법 시장, 제형별, 2020-2032년
- 정제
- 캡슐 및 구미
- 주사액
- 분말
- 기타
제7장 세계의 비타민 D 요법 시장, 용도별, 2020-2032년
- 골다공증
- 구루병
- 근력 저하
- 피부질환
- 자가면역질환
- 기타
제8장 세계의 비타민 D 요법 시장, 연령층별, 2020-2032년
- 어린이
- 성인
- 고령자
제9장 세계의 비타민 D 요법 시장, 성별, 2020-2032년
- 여성
- 남성
제10장 세계의 비타민 D 요법 시장, 유통 채널별, 2020-2032년
- 병원 약국
- 소매 약국
- 온라인 약국
제11장 세계의 비타민 D 요법 시장, 최종 사용자별, 2020-2032년
- 병원
- 전문 클리닉
- 재택치료
- 재활센터
- 기타(학술기관 및 연구기관)
제12장 세계의 비타민 D 요법 시장, 지역별, 2020-2032년
- 북미
- 미국
- 캐나다
- 라틴아메리카
- 브라질
- 아르헨티나
- 멕시코
- 기타 라틴아메리카
- 유럽
- 독일
- 영국
- 스페인
- 프랑스
- 이탈리아
- 러시아
- 기타 유럽
- 아시아태평양
- 중국
- 인도
- 일본
- 호주
- 한국
- ASEAN
- 기타 아시아태평양
- 중동
- GCC 국가
- 이스라엘
- 기타 중동
- 아프리카
- 남아프리카
- 북아프리카
- 중앙 아프리카
제13장 경쟁 구도
- Abbott Laboratories
- Pfizer Inc.
- GlaxoSmithKline(GSK)
- Merck & Co., Inc.
- Sanofi
- Cadila Healthcare Ltd.
- Alkem Laboratories Ltd.
- Ortho Molecular Products
- Biotics Research Corporation
- Atrium Innovations
- Lonza Group Ltd.
- BASF SE
- DSM-Firmenich
- Adisseo France SAS
- Theramex
제14장 분석가 추천
- 기회
- 애널리스트의 견해
- Coherent Opportunity Map
제15장 참고문헌과 조사방법
- 참고문헌
- 조사 방법
- 출판사에 대해
Vitamin D Therapy Market is estimated to be valued at USD 2.64 Bn in 2025 and is expected to reach USD 5.62 Bn by 2032, growing at a compound annual growth rate (CAGR) of 11.3% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 2.64 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 11.30% | 2032 Value Projection: | USD 5.62 Bn |
The global vitamin D therapy market represents a rapidly expanding segment within the broader pharmaceutical and nutraceutical industries, driven by increasing awareness of vitamin D deficiency's widespread prevalence and its correlation with numerous health conditions. Vitamin D therapy encompasses various formulations including oral supplements, injectable preparations, and fortified products designed to address deficiency states and support optimal bone health, immune function, and overall wellness.
The market has witnessed significant growth due to rising incidences of osteoporosis, rickets, and other bone-related disorders, particularly among aging populations and individuals with limited sun exposure. Healthcare professionals increasingly recognize vitamin D's role beyond skeletal health, including its potential benefits for cardiovascular health, immune system support, and chronic disease prevention. The therapeutic applications span across multiple medical specialties, from endocrinology and orthopedics to general medicine and preventive healthcare. Market expansion is further supported by growing consumer awareness, improved diagnostic capabilities for detecting deficiency, and regulatory approvals for new therapeutic formulations.
Market Dynamics
The global vitamin D therapy market is propelled by several key drivers, including the alarming prevalence of vitamin D deficiency worldwide, which affects approximately one billion people globally, creating substantial demand for therapeutic interventions. The aging global population significantly drives market growth, as elderly individuals face increased risk of deficiency due to reduced skin synthesis capacity and limited dietary intake, necessitating therapeutic supplementation to prevent osteoporosis, fractures, and related complications. Rising awareness among healthcare professionals and consumers about vitamin D's multifaceted health benefits beyond bone health, including immune system support, cardiovascular protection, and potential anti-inflammatory properties, expands the therapeutic applications and market scope.
However, market growth faces notable restraints, including regulatory complexities surrounding dosage recommendations and safety concerns, as excessive vitamin D intake can lead to toxicity and hypercalcemia, creating hesitancy among healthcare providers and patients. The lack of standardized global guidelines for vitamin D testing and treatment protocols creates market fragmentation and limits consistent adoption across different regions. Additionally, the availability of low-cost generic supplements and over-the-counter alternatives may impact the premium therapeutic segment's growth potential. Despite these challenges, significant opportunities emerge from expanding applications in emerging therapeutic areas such as autoimmune disorders, cancer prevention, and mental health, supported by ongoing clinical research demonstrating vitamin D's broader physiological roles. The growing trend toward personalized medicine creates opportunities for targeted vitamin D therapies based on individual genetic profiles and specific deficiency patterns, while increasing healthcare infrastructure in emerging markets presents substantial expansion potential for manufacturers seeking to address unmet medical needs in underserved populations.
Key Features of the Study
- This report provides in-depth analysis of the global vitamin D therapy market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global vitamin D therapy market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Abbott Laboratories, Pfizer Inc., GlaxoSmithKline (GSK), Merck & Co., Inc., Sanofi, Cadila Healthcare Ltd., Alkem Laboratories Ltd., Ortho Molecular Products, Biotics Research Corporation, Atrium Innovations, Lonza Group Ltd., BASF SE, DSM-Firmenich, Adisseo France S.A.S., and Theramex
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global vitamin D therapy market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global vitamin D therapy market
Market Segmentation
- Type Insights (Revenue, USD Bn, 2020 - 2032)
- Over-the-Counter (OTC) Drugs
- Prescription Drugs
- Route of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Oral
- Parenteral (injectables)
- Dosage Form Insights (Revenue, USD Bn, 2020 - 2032)
- Tablets
- Capsules/Gummies
- Injections
- Powder
- Other Liquid Solutions
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Osteoporosis
- Rickets
- Muscle Weakness
- Skin Diseases
- Autoimmune Disorders
- Others
- Age Group Insights (Revenue, USD Bn, 2020 - 2032)
- Children
- Adults
- Geriatric
- Gender Insights (Revenue, USD Bn, 2020 - 2032)
- Female
- Male
- Distribution Channel Insights (Revenue, USD Bn, 2020 - 2032)
- Hospital Pharmacies
- Retail Pharmacies
- Online Pharmacies
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Specialty Clinics
- Homecare Settings
- Rehabilitation centers
- Others (Academic and Research Institutions)
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Abbott Laboratories
- Pfizer Inc.
- GlaxoSmithKline (GSK)
- Merck & Co., Inc.
- Sanofi
- Cadila Healthcare Ltd.
- Alkem Laboratories Ltd.
- Ortho Molecular Products
- Biotics Research Corporation
- Atrium Innovations
- Lonza Group Ltd.
- BASF SE
- DSM-Firmenich
- Adisseo France S.A.S.
- Theramex
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Vitamin D Therapy Market, By Type
- Global Vitamin D Therapy Market, By Route of Administration
- Global Vitamin D Therapy Market, By Dosage Form
- Global Vitamin D Therapy Market, By Application
- Global Vitamin D Therapy Market, By Age Group
- Global Vitamin D Therapy Market, By Gender
- Global Vitamin D Therapy Market, By Distribution Channel
- Global Vitamin D Therapy Market, By End User
- Global Vitamin D Therapy Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Vitamin D Therapy Market, By Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Over-the-Counter (OTC) Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Prescription Drugs
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Vitamin D Therapy Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Parenteral (injectables)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Vitamin D Therapy Market, By Dosage Form, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Tablets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Capsules/Gummies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Injections
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Powder
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Liquid Solutions
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Vitamin D Therapy Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Osteoporosis
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rickets
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Muscle Weakness
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Skin Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Vitamin D Therapy Market, By Age Group, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Children
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Adults
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Vitamin D Therapy Market, By Gender, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
10. Global Vitamin D Therapy Market, By Distribution Channel, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospital Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Retail Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Online Pharmacies
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
11. Global Vitamin D Therapy Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Homecare Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Rehabilitation centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (Academic and Research Institutions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
12. Global Vitamin D Therapy Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025, 2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Dosage Form, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Gender, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End User, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
13. Competitive landscape
- Abbott Laboratories
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Cadila Healthcare Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Alkem Laboratories Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Ortho Molecular Products
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biotics Research Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Atrium Innovations
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Lonza Group Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- BASF SE
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- DSM-Firmenich
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Adisseo France S.A.S.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Theramex
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
14. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
15. References and Research Methodology
- References
- Research Methodology
- About us
